Sex differences in drug-induced changes in ventricular repolarization
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Journal of Electrocardiology
- Vol. 48 (6) , 1081-1087
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration’s Critical Path Initiative
- U.S. Food and Drug Administration’s Office of Women’s Health
- Oak Ridge Institute for Science and Education
- U.S. Department of Energy
- U.S. Food and Drug Administration
- Ministerio de Economía y Competitividad (MINECO), Spain (TIN2013-41998-R)
- Grupo Consolidado BSICoS from DGA (Aragón)
- European Social Fund (EU)
This publication has 22 references indexed in Scilit:
- Investigation of potential mechanisms of sex differences in quinidine-induced torsade de pointes riskJournal of Electrocardiology, 2015
- Mechanisms of sex and age differences in ventricular repolarization in humansAmerican Heart Journal, 2014
- Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTcmodelling in a phase 1 study with oral rac-sotalolBritish Journal of Clinical Pharmacology, 2014
- L‐Type Calcium Current Reactivation Contributes to Arrhythmogenesis Associated with Action Potential TriangulationJournal of Cardiovascular Electrophysiology, 2007
- Drug-Induced QT Prolongation in Women During the Menstrual CycleJAMA, 2001
- Greater quinidine-induced QTc interval prolongation in womenClinical Pharmacology & Therapeutics, 2000
- HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel FamilyScience, 1995
- Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular DrugsJAMA, 1993
- Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.Circulation Research, 1989
- The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration‐effect relationships.British Journal of Clinical Pharmacology, 1981